Cypress Capital Group has filed its 13F form on November 08, 2024 for Q3 2024 where it was disclosed a total value porftolio of $879 Million distributed in 439 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Core S&P 500 ETF with a value of $51.5M, Apple Inc. with a value of $49.3M, Eli Lilly & CO with a value of $48.6M, Microsoft Corp with a value of $36.2M, and Abb Vie Inc. with a value of $22.5M.

Examining the 13F form we can see an increase of $52.4M in the current position value, from $827M to 879M.

Below you can find more details about Cypress Capital Group portfolio as well as his latest detailed transactions.

Portfolio value $879 Million
Technology: $172 Million
ETFs: $167 Million
Healthcare: $143 Million
Financial Services: $90.7 Million
Consumer Cyclical: $70.2 Million
Industrials: $69.2 Million
Consumer Defensive: $54 Million
Energy: $48.5 Million
Other: $64.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 439
  • Current Value $879 Million
  • Prior Value $827 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 08, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 28 stocks
  • Additional Purchases 108 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 159 stocks
Track This Portfolio

Track Cypress Capital Group Portfolio

Follow Cypress Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.